These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients. Ganschow R; Schulz T; Meyer T; Broering DC; Burdelski M J Pediatr Gastroenterol Nutr; 2004 Feb; 38(2):198-203. PubMed ID: 14734884 [TBL] [Abstract][Full Text] [Related]
27. Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review. Sprangers B; Riella LV; Dierickx D Am J Kidney Dis; 2021 Aug; 78(2):272-281. PubMed ID: 33774079 [TBL] [Abstract][Full Text] [Related]
28. A multicenter survey on post-transplant lymphoproliferative disorders in pediatric heart transplant recipients: A case for development of consensus guidelines for screening, surveillance, and treatment? Weisert M; Harake D; Hede S; Russell M; Alejos J; Menteer J Pediatr Transplant; 2020 Aug; 24(5):e13730. PubMed ID: 32416037 [TBL] [Abstract][Full Text] [Related]
32. Impact of EBV infection and immune function assay for lymphoproliferative disorder in pediatric patients after liver transplantation: A single-center experience. Qin T; Gu XQ; Jeong SS; Song YY; Liu JC; Zheng JX; Xue F; Xia Q Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):3-11. PubMed ID: 31932195 [TBL] [Abstract][Full Text] [Related]
33. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature. Kataoka K; Seo S; Sugawara Y; Ota S; Imai Y; Takahashi T; Fukayama M; Kokudo N; Kurokawa M Leuk Lymphoma; 2010 Aug; 51(8):1494-501. PubMed ID: 20578817 [TBL] [Abstract][Full Text] [Related]
34. Posttransplant lymphoproliferative disorder in pediatric liver transplantation. Uribe M; Hunter B; Alba A; Calabrán L; Flores L; Soto P; Herzog C Transplant Proc; 2009; 41(6):2679-81. PubMed ID: 19716000 [TBL] [Abstract][Full Text] [Related]
35. Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients. Zierhut H; Kanzelmeyer N; Buescher A; Höcker B; Mauz-Körholz C; Tönshoff B; Metzler M; Pohl M; Pape L; Maecker-Kolhoff B Pediatr Transplant; 2021 Sep; 25(6):e14042. PubMed ID: 34021949 [TBL] [Abstract][Full Text] [Related]
36. Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child. Hayashida M; Ogita K; Matsuura T; Takahashi Y; Nishimoto Y; Ohga S; Hara T; Soejima Y; Taketomi A; Maehara Y; Kohashi K; Tsuneyoshi M; Taguchi T Pediatr Transplant; 2007 Sep; 11(6):671-5. PubMed ID: 17663692 [TBL] [Abstract][Full Text] [Related]
38. Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia. Hyun H; Park E; Cho M; Min SI; Ha J; Kang HJ; Shin HY; Ha IS; Cheong HI; Ahn YH; Kang HG J Korean Med Sci; 2019 Aug; 34(30):e203. PubMed ID: 31373185 [TBL] [Abstract][Full Text] [Related]
39. [Post-transplantation lymphoproliferative disorder in childhood]. Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879 [TBL] [Abstract][Full Text] [Related]
40. Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation. Matsukura T; Yokoi A; Egawa H; Kudo T; Kawashima M; Hirata Y; Tanaka H; Kagajo K; Wada H; Tanaka K Clin Transplant; 2002 Apr; 16(2):107-12. PubMed ID: 11966780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]